Structure of Ericamycin Having a 2-Azhexaphene Ring System
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-02-25
著者
-
Kondo S
Institute Of Microbial Chemistry
-
KONDO Shinichi
Institute of Microbial chemistry
-
Ikeda Y
Institute Of Microbial Chemistry
-
IKEDA Yoko
Institute of Microbial Chemistry
-
IKEDA Daishiro
Institute of Microbial Chemistry
-
NISHIZUKA Toshio
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
GOMI Shuichi
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
Ikeda Yohikazu
Research Institute Of Life Science Snow Brand Milk Products Co. Ltd.
-
Ikeda D
Numazu Bio-medical Research Institute Microbial Chemistry Research Foundation
-
Ikeda Y
Research Institute Of Life Science Snow Brand Milk Products Co. Ltd.
-
Gomi S
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Gomi Shuichi
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Niizato Tetsutaro
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Kondo Shinichi
Nimura Genetic Solutions Co. Ltd.
-
Kondo Shinichi
Nimura Genetic Solutions
-
Ikeda Daishiro
Institute of Bioorganic Chemistry
関連論文
- Synthesis and antimetastatic activity of 6-Trichloracetamido and 6-Guanidino Analogues of Siastatin B
- Synthesis and Activity of 3-epi-Actinobolin
- Synthesis and Activities of Bactobolin Derivatives Based on the Alteration of the Functionality at C-3 Position
- Isolation of a Novel Cyclic Hexadepsipeptide Pipalamycin from Streptomyces as an Apoptosis-inducing Agent
- Morphological Alterations of Saccharomyces cerevisiae Induced by Benanomicin A, an Antifungal Antibiotic with Mannan Affinity
- Structure of Ericamycin Having a 2-Azhexaphene Ring System
- Mode of Antifungal Action of Benanomicin A in Saccharomyces cerevisiae
- Selective Deoxygenation and O-Methylation of Benanomicin A:Synthesis of 9-Deoxy-, 9-O-Methyl- and 14-O-Methylbenanomicin A
- A Synthetic Approach to Benanomicin A 2. Synthesis of the Substituted 5,6-Dihydrobenzo[a]naphthacenequinone
- A Synthetic Approach to Benanomicin A 1. Synthesis of 5,6-Dihydrobenzo[a]naphthacenequinone
- Synthesis an Optically Active α-Tetralone : A Key Intermediate to Natural Benanomicinone
- Structures of Two Remarkable Dimerization Products of Sarkomycin
- A Synthetic Approach to Benanomicin A : Synthesis of the Substitute 5, 6-Dihydrobenzo[a]naphthacenequinone
- Antifungal Antibiotic Benanomicin A Increases Susceptibility of Candida albicans to Phagocytosis by Murine Macrophages
- Antibacterial Activity and Nephrotoxicity of Two Novel 2"-Amino Derivatives of Arbekacin
- Binding of Benanomicin A to Fungal Cells in Reference to its Fungicidal Action
- New Bellenamine Homologs Inhibiting Human Immunodeficiency Virus Type 1 Infectivity
- Isolation from Streptomyces of a Novel Naphthoquinone Compound, Naphthablin, That Inhibits Abl Oncogene Functions
- Biosynthesis of Neothramycin
- New Types of Liposidomycins Which Inhibit Bacterial Peptidoglycan Synthesis Produced by Streptomyces
- Selective Inhibition of the Bacterial Peptidoglycan Biosynthesis by the New Types of Liposidomycins
- New Types of Liposidomycins that Inhibit Bacterial Peptidoglycan Synthesis and are Produced by Streptomyces II. Isolation and Structure Elucidaion
- New Types of Liposidomycins that Inhibit Bacterial Peptdoglycan Synthesis and are Produced by Streptomyces I. Producing Organism and Medium Components
- Bispolides, Novel 20-Membered Ring Macrodiolide Antibiotics from Microbispora
- Inhibition of Pulmonary Metastases and Tumor Cell Invasion in Experimental Tumors by Sodium _D-Glucaro-δ-lactam (ND2001)
- ICM0301s, New Angiogenesis Inhibitors from Aspergillus sp. F-1491 : II. Physico-chemical Properties and Structure Elucidation
- Specific Inhibition of Hypoxia-inducible Factor (HIF)-1α Activation and of Vascular Endothelial Growth Factor (VEGF) Production by Flavonoids(Biochemistry/Molecular Biology)
- Anthracyclines, Small-Molecule Inhibitors of Hypoxia-Inducible Factor-1 Alpha Activation(Molecular and Cell Biology)
- HIF-1-Dependent VEGF Reporter Gene Assay by a Stable Transformant of CHO Cells
- Induction of p16/INK4a Gene Expression and Cellular Senescence by Toyocamycin(Biochemistry/Molecular Biology)
- Deoxynybomycin Is a Selective Anti-Tumor Agent Inducing Apoptosis and Inhibiting Topoisomerase I
- Identification of Active Substances from Streptomyces Culture Fluids Using p53-Independent Expression of p21/WAF1/Cip1 Gene and Their Mode of Action
- Kigamicins, Novel Antitumor Antibiotics I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities
- Inhibitory Activity of Dome Formation in LLC-PK_1 Cells Is a Selective Index of Aminoglycoside Nephrotoxicity
- Tyropeptins A and B, New Proteasome Inhibitors Produced by Kitasatospora sp. MK993-dF2 : II. Structure Determination and Synthesis
- Heliquinomycin, a New Inhibitor of DNA Helicase, Produced by Streptomyces sp. MJ929-SF2 II. Structure Determination of Heliquinomycin
- Inhibition of Tumor Cell Haptotaxis by Sodium D-Glucaro-δ-lactam (ND2001)
- Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4 II. Structure Determination
- Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4 I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities
- A New Cytotoxic 2H-Pyran Compound Produced by Acid Treatment of the Fermentation Broth of Streptomyces Sp.
- SNF-4794: New Enzyme Inhibitors Produced by Chaetomella sp.
- Acetylation of Aminoglycoside Antibiotics with 6'-Methylamino Group, Istamycin B and Micronomicin, by a Novel Aminoglycoside 6'-Acetyltransferase of Actinomycete Origin
- Double Stage Activity in Aminoglycoside Antibiotics
- Role of Aminoglycoside 6'-Acetyltransferase in a Novel Multiple Aminoglycoside Resisdtance of an Actinomycete Strain #8: Inactivation of Aminoglycosides with 6'-Amino Group Except Arbekacin and Neomycin
- Enzymatic 1-N-Acetylation of Paromomycin by an Actinomycete Strain #8 with Multiple Aminoglycoside Resistance and Paromomycin Sensitivity
- The Novel Enzymatic 3"-N-Acetylation of Arbekacin by an Aminoglycoside 3-N-Acetyltransferase of Streptomyces Origin and the Resulting Activity
- Enzymatic 2'-N-Actylation of Arbekacin and Antibiotic Activity of Its Product
- Characterization of a Bifunctional Aminoglycoside-Modifying Enzyme with Novel Substrate Specificity and Its Gene from a Clinical Isolate of Methicillin-Resistant Staphylococcus aureus with High Arbekacin Resistance
- Effect of Cytogenin, a Novel Immunomodulator, on Streptozotocin-induced Diabetes in Mice
- Structure of Furanocandin, a New Antifungal Antibiotic from Tricothecium sp.
- PB130 SIASTATIN B, A POTENT SIALIDASE INHIBITOR : THE TOTAL SYNTHESIS, ABSOLUTE CONFIGURATION AND BIOLOGICAL ACTIVITY
- ICM0301s, New Angiogenesis Inhibitors from Aspergillus sp. F-1491 : I. Taxonomy, Fermentation, Isolation and Biological Activities
- Tripropeptins, Novel Antimicrobial Agents Produced by Lysobacter sp. II. Structure Elucidation
- Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation
- Kigamicins, Novel Antitumor Antibiotics II. Structure Determination
- Absolute Configuration of Kigamicins A, C and D
- Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin
- The Decrease of Cytochrome c Oxidase Activity by 15-Deoxyspergualin Results in Enhancement of XTT Reduction in Cultured Cells
- Stimulation of Cellular XTT Reduction by Cytochrome Oxidase Inhibitors
- PP2A Inhibitors, Harzianic Acid and Related Compounds Produced by Fungus Strain F-1531
- Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis
- Augmentation of Cellular Immunity by Kigamicin D
- Antitumor Effect of Kigamicin D on Mouse Tumor Models
- Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions
- A New Terrein Glucoside, a Novel Inhibitor of Angiogenin Secretion in Tumor Angiogenesis
- A New Proteasome Inhibitor, TP-110, Induces Apoptosis in Human Prostate Cancer PC-3 Cells
- Inhibitory Activity of the Hypoxia-inducible Factor-1 Pathway by Tartrolone C
- Prevention of Neomycin-induced Nephrotoxic Event in Pig Proximal Tubular Epithelial Cell Line by Apolipoprotein E3
- Increased ABCB1 Expression in TP-110-Resistant RPMI-8226 Cells
- New Aldobiuronic Acid, 3-O-α-D-Glucopyranuronosyl-L-rhamnopyranose, from an Acidic Polysaccharide of Chlorella vulgaris
- Inhibition of Nitric Oxide Synthase Induction by 15-Deoxyspergualin in a Cultured Macrophage Cell Line, J744A.1 Activated with IFN-γ and LPS
- Semisynthetic aminoglycoside antibiotics : Development and enzymatic modifications
- A New Glycosylated Dihydrophaseic Acid from Cacao Germs (Theobroma cacao L.)
- New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells
- Ceramidastin, a novel bacterial ceramidase inhibitor, produced by Penicillium sp. Mer-f17067
- In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds
- Promising lead compounds for novel antiprotozoals
- In vitro and in vivo antiprotozoal activities of bispolides and their derivatives
- NBRI17671, a new antitumor compound, produced by Acremonium sp. CR 17671
- NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716
- Citric acid inhibits a bacterial ceramidase and alleviates atopic dermatitis in an animal model
- Total synthesis of minosaminomycin.
- A synthesis of 3'-deoxybutirosin B.
- Total syntheses of indicine N-oxide, intermedine N-oxide, and their enantiomers using carbohydrate as a chiral educt.
- Studies on lignan lactone antitumor agents. IV. Synthesis of glycosidic lignan variants related to .ALPHA.-peltatin.
- Studies on lignan lactone antitumor agents. V. 1-O-(aminoethyl) ther of 4'-O-demethyl-1-epipodophyllotoxin.
- Suppression of type II collagen-induced arthritis by ICM0301B, a new angiogenesis inhibitor